Search Within

Alexander Noor Shoushtari

Formats
  1. Journal Article (112)
  2. Meeting Abstract (105)
  3. Research Letter (11)
  4. Editorial (7)
  5. Review (4)
  6. Book Section (3)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (244)
  2. Hematologic Malignancies, Division of (244)
  3. Melanoma Disease Management Team (244)
  4. Melanoma and Immunotherapeutics Service (244)
  5. Solid Tumor Oncology Division (244)
  6. GSK Faculty (86)

More Groups

People
  1. Michael Postow (63)
  2. Jedd Wolchok (49)
  3. Margaret Callahan (45)
  4. Paul Chapman (45)
  5. Katherine Panageas (34)
  6. Parisa Momtaz (32)

More People

Years
  1. 2025 (4)
  2. 2024 (22)
  3. 2023 (25)
  4. 2022 (38)
  5. 2021 (38)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (66)
  2. Annals of Oncology (22)
  3. Journal for ImmunoTherapy of Cancer (17)
  4. Clinical Cancer Research (11)
  5. Cancer Research (7)
  6. Melanoma Research (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (69)
  2. Oxford University Press (29)
  3. American Association for Cancer Research (21)
  4. Biomed Central Ltd (21)
  5. Nature Publishing Group (14)
  6. Elsevier Inc. (13)

More Publishers

Results (244)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The effect of LNS8801 alone and in combination with pembrolizumab in patients with metastatic uveal melanoma
    Meeting Abstract

    Shoushtari, A. N.; Chaney, M. F.; Cohen, J. V.; Garyantes, T.; Lin, J. J.; Ishizuka, J. J.; Mita, A. C.; Mita, M. M.; Muller, C.; Natale, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Meeting Abstract

    Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: A phase 1 study
    Journal Article

    Hamid, O.; Hassel, J. C.; Shoushtari, A. N.; Meier, F.; Bauer, T. M.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P. C.; Mauch, C.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: Mutational signature analysis and immunotherapy response
    Journal Article

    Kasago, I. S.; Chatila, W. K.; Lezcano, C. M.; Febres-Aldana, C. A.; Schultz, N.; Vanderbilt, C.; Dogan, S.; Bartlett, E. K.; D'Angelo, S. P.; Tap, W. D.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: A propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
    Journal Article

    Weber, J. S.; Poretta, T.; Stwalley, B. D.; Sakkal, L. A.; Du, E. X.; Wang, T.; Chen, Y.; Wang, Y.; Betts, K. A.; Shoushtari, A. N.
    Cancer Immunology, Immunotherapy (2023)

    Fulltext@MSK | Save
  • More than just skin-deep: A review of imaging’s role in guiding CAR T-cell therapy for advanced melanoma
    Review

    Prendergast, C. M.; Capaccione, K. M.; Lopci, E.; Das, J. P.; Shoushtari, A. N.; Yeh, R.; Amin, D.; Dercle, L.; De Jong, D.
    Diagnostics (2023)

    Fulltext@MSK | Save
  • Factors associated with improved overall survival for patients undergoing embolization of metastatic melanoma
    Meeting Abstract

    Haghani, L.; Zhan, C.; Yarmohammadi, H.; Ziv, E.; Cornelis, F.; Gonzalez Aguirre, A.; Moussa, A.; Santos, E.; Shoushtari, A.; Erinjeri, J.
    Journal of Vascular and Interventional Radiology (2023)

    Fulltext@MSK | Save